MAPK1 and hepatocellular carcinoma: Based on the aforementioned information, we proposed a hypothesis that BMP2 affects the progression of HCC by regulating the MAPK/p38 signaling pathway and aim to verify this hypothesis to provide some novel insights for HCC treatment.